Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ?Orphan

DEA 66

DEA Clinical Trials THC Research and Development 66

MedicalJane

MAY 21, 2020

The UNM researchers set out to examine the effectiveness of consuming “legal” hemp oil extracted from the whole Cannabis plant. A chronic neuropathic pain model was used that exposed mice to post-operative neuropathic pain equivalent to several years of chronic pain in human patients. Westlund, Department of Anesthesiology.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Cannabis Law Report

MAY 29, 2019

The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. All intellectual property from the trials will be owned by MGC, which is funding the research. Here’s the press release.

Cultivation 40

Cultivation Pharmaceutical Clinical Trials Extraction 40

Cannabis Law Report

SEPTEMBER 12, 2022

Our mushrooms are some of the most tested products on the planet as we cross the lines between Pharmaceutical, Agriculture, Botanical, and Food testing quality assays,” said Optimi Chief Science Officer, Justin Kirkland. The harvest includes the following psilocybin-containing mushroom strains: Koh Samui.

History 52

History Clinical Trials Legalization Research and Development 52

The Cannigma

MARCH 7, 2022

Therefore, it makes sense that CBN is most commonly found in aged or improperly stored cannabis, and hardly ever present in fresh flower or low-temp extractions. What can the current clinical trials tell us? THC and is extracted from hemp, it’s generally considered legal. Converting THC to CBN happens through oxidation.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Veriheal

NOVEMBER 17, 2020

He ran clinical trials for big pharma’s GW Pharmaceuticals research division on Epidiolex. Epidiolex is an FDA approved cannabis-based pharmaceutical manufactured drug used in the treatment of seizures. Anup Patel is the most perplexing. Dr. Patel is a member of the Nationwide Children’s Hospital.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

SpeedWeed

JULY 23, 2021

“We’re interested in how cannabinoids affect the nervous system, the brain, and in particular, we’re very interested in Alzheimer’s disease,” said Dr. Tyrell Towle, director of chemistry and extraction at MedPharm. We will have 30 patients in the first study with multiple forms of dementia,” CEO Albert Gutierrez explained.

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

Cannabis Law Report

DECEMBER 14, 2019

The uptick has been represented in the patient count, as well. Although we note the early stage of the sector in Australia and the associated volatility of a nascent industry, over the same period patient numbers domestically have continued to soar,” Bell and Smith wrote in their note. Learn to profit from cannabis companies.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Cannabis Law Report

OCTOBER 10, 2019

Clinical studies are about to get underway at an Australia university, to track changes in actual dementia patients to see if cannabis can help with dementia and related issues. In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly.

Treatment 40

Treatment Clinical Trials Sleep Pharmaceutical 40

Cannabis Law Report

NOVEMBER 29, 2019

These include the potential to relieve symptoms like nausea and vomiting in cancer patients after undergoing chemotherapy treatment. THC has shown the potential to help with appetite among patients with eating disorders. It also has the potential to help patients with neurodegenerative diseases and relieving pain in cancer patients.

Oil 104

Oil THC Cannabinoids Research and Development 104

Cannabis Law Report

JULY 6, 2021

Dr. Bankole Johnson was also the founder of NASDAQ listed Adial Pharmaceuticals (NASDAQ: ADIL) and currently serves as its Chief Medical Officer. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.” ” About Ehave, Inc. Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. A doctor who applies to the TGA on behalf of a patient must provide a clinical justification.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

APRIL 1, 2019

Selling dried cannabis to pharmaceutical companies as well as Cannabidiol (CBD) and Tetrahydrocannabinol (THC) extracts as soon as it is licensed, is the intention of Thailand’s tobacco authority among new measures to turn a profit on its dwindling cigarette business. 49 Percent Foreign Shareholding Allowed.

Research and Development 40

Research and Development Pharmaceutical Clinical Trials DEA 40

Cannabis Law Report

FEBRUARY 3, 2022

Patients suffering from chronic diseases, like Parkinson’s, Alzheimer’s, cancer, and many neurological disorders, are administered cannabis. The presence of major key players, pharmaceutical and biotechnology industries worldwide, and their experimental approach drives the cannabis market growth. Gw Pharmaceuticals plc.

Indica 52

Indica Oil Legalization Research and Development 52

Canna Care Docs

DECEMBER 11, 2018

Arthritis: The use of CBD, a non-psychoactive chemical found in cannabis which can be extracted separately from psychoactive THC, has been shown in multiple studies to be effective in taking on arthritis pain and discomfort. Another important aspect for seniors is that medicinal cannabis users tend to take less pharmaceutical drugs.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

The Cannigma

JULY 1, 2022

These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The highest quality form of scientific research, in terms of whether the results provide predictive power (which is what science is all about), is the placebo controlled, double blind, randomized clinical trial.

Research and Development 108

Research and Development Data THC Clinical Trials 108

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBD extraction methods.

CBD 122

CBD Research and Development Epilepsy Extraction 122

CannaMD

AUGUST 8, 2020

The one exception is pharmaceutical-grade CBD products that have been approved by the FDA, which currently only includes one medication: Epidiolex. Prior to receiving FDA approval, Epidiolex underwent a number of clinical trials establishing the medical efficacy of CBD. CBD is also a favorite among insomnia patients.

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

Project CBD

OCTOBER 26, 2023

I advise my patients to stop using cannabis for 36 to 48 hours prior to chemotherapy and to start again 36 to 48 hours after their session. Phase 2 is the first study level conducted on patients with the disease for which the drug is intended and determines whether it is safe and effective.

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. It covers the pipeline drug profiles, including clinical and nonclinical stage products. Ganaxolone: Marinus Pharmaceuticals. Epilepsy Emerging Drugs.

Epilepsy 52

Epilepsy Clinical Trials Research and Development Pharmaceutical 52

Project CBD

MAY 3, 2023

Dr. Goldstein has treated thousands of patients with medical cannabis. She is the medical director of Canna-Centers Wellness & Education and the clinical advisor to Cannformatics. Remember, the pharmaceutical model is “this medicine addresses this specific target.” I have used it in some of my patients with autism.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

SpeedWeed

MARCH 28, 2021

CANNABIS CULTURE – The results are now in after the first-ever legal clinical trial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? That’s what most providers are worried about when their patients with PTSD decide to try cannabis.”.

Clinical Trials 52

Clinical Trials DEA Treatment THC 52

Cannabis Law Report

OCTOBER 22, 2021

The drug is currently in phase III stage of development for the treatment of spasticity in patients with multiple sclerosis not showing sufficient response to their current anti-spasticity treatment. Cannabis oil: TO Pharmaceuticals TO Pharma is developing next-generation cannabinoid therapies for debilitating diseases. Key Players.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Project CBD

FEBRUARY 28, 2023

1 SPINS’ CBD category typically includes sales of products that contain hemp-based CBD extracts, including CBD oils, gummies, and capsules. Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners. (THC is the primary psychoactive compound in cannabis.) Epilepsy Behav.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

OCTOBER 18, 2021

The drug is currently in phase III stage of development for the treatment of spasticity in patients with multiple sclerosis not showing sufficient response to their current anti-spasticity treatment. Lenabasum: Corbus Pharmaceuticals. Cannabis oil: TO Pharmaceuticals. INM-755: InMed Pharmaceuticals. TO Pharmaceuticals.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

Cannabis Law Report

JANUARY 9, 2019

Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment. Phoenix are conducting short-term CBD oil studies with local patients at the country’s general hospital. Tindall cites the positive strides GW Pharmaceuticals have made on overseas markets as the regulatory playbook to follow.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Info

OCTOBER 11, 2019

Now, clinical studies are about to get underway at an Australia university, to track changes in actual dementia patients to see if cannabis can help. In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Cannabis Law Report

FEBRUARY 3, 2022

Using its state-of-the-art combinatorial machine for automatic packaging and its extraction machine for oil production, MediCane intends to process its organic production first for the Israeli market and later for global markets and will selectively offer toll manufacturing services to other local cannabis companies.

Clinical Trials 52

Clinical Trials Research and Development Packaging Oil 52

The Cannigma

MAY 7, 2021

In Europe, Murphy explains, cannabis products are held to the same standards of accountability and repeatability as other pharmaceuticals. There were somewhat of a, I want to say grey, but it wasn’t the pharma routes for patients in the US who wanted to get certain products, you know?

Supply Chain 120

Supply Chain Patients Access Hemp 120

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I Mara: I got in as a, a patient both for myself and for my husband.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. To date, very few human clinical trials have been conducted to assess the effectiveness of THC or CBD in treating cancer. The answer: Maybe!

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. I have many patients that want to use cannabis, and they who ask me what product should they get? I include pharmaceutical drugs in that category. Cannabis is a really special case.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

JULY 15, 2022

“It’s very important from our perspective to ensure that the Australian patient gets medicine first. The first medicinal cannabis ‘mother’ plants are expected to be imported from Israel within a month, with manufacturing scheduled to begin within the first half of this year, to supply 5,000 Australian patients.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

MAY 13, 2019

Medical professionals want more information about medicinal cannabis before they start prescribing it to patients, a new study has found. Screening for relevancy, full-text review, data extraction, and risk of bias were completed by two independent investigators. Pre-defined inclusion and exclusion criteria were applied uniformly.

Medicine 45

Medicine Research and Development Clinical Trials Data 45